Rajaa A. Mirghani - Concepedia

Author

Rajaa A. Mirghani

Karolinska Institutet

Also Known As

Mirghani, R., R MIRGHANI, R. A Mirghani, R. A. Mirghani, R. Mirghani, R.A. Mirghani, Rajaa A. Mirghani, Rajaa Mirghani

Publications

833

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Stockholm University College of Music Education University of Khartoum King Fahd Medical City

About

Rajaa A. Mirghani is an author at Karolinska Institutet specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	323
2	Biochemistry	2	2	56
3	Natural Sciences	1	1	35
4	Public Health	1	1	21
5	Biostatistics	1	1	21

Rajaa A. Mirghani

Publications

819

Citations

H-Index

Page 1

	Year	Citations
4β-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians Ulf Diczfalusy, Jun Miura, Hyung‐Keun Roh, Pharmacogenetics and Genomics	2008	145
Pharmacogenetic Studies of Paclitaxel in the Treatment of Ovarian Cancer Henrik Gréen, Peter Söderkvist, Per Rosenberg, Basic & Clinical Pharmacology & Toxicology	2008	119
CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population Rajaa A. Mirghani, Jane Sayi, Eleni Aklillu, Pharmacogenetics and Genomics	2006	86
Simultaneous determination of quinine and four metabolites in plasma and urine by high-performance liquid chromatography Rajaa A. Mirghani, Örjan Ericsson, James M. Cook, Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineDrug PurityBioanalysisMass Spectrometry	2001	58
Metabolism and elimination of quinine in healthy volunteers Rajaa A. Mirghani, Urban Hellgren, Leif Bertilsson, European Journal of Clinical Pharmacology Pharmacological StudyMedicineHealthy VolunteersToxicologyPharmacotherapy	2003	52
The roles of cytochrome P450 3A4 and lA2 in the 3-hydroxylation of quinine in vivo Rajaa A. Mirghani, Urban Hellgren, P WESTERBERG, Clinical Pharmacology & Therapeutics	1999	46
CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity Henrik Gréen, Karin Skoglund, Franz Rommel, European Journal of Clinical Pharmacology Hematological MalignancyCyp3a Activity InfluencesChronic Myeloid LeukemiaVivo Cyp3a ActivityMedicine	2010	45
Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers Annika Allqvist, Jun Miura, Leif Bertilsson, European Journal of Clinical Pharmacology Medicinal ChemistryMedicineDifferent EnantiomersPharmacotherapyPharmacology	2007	36
Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria Ishraga I. Abdelrahim, I. Adam, Gehad ElGhazali, Journal of Clinical Pharmacy and Therapeutics	2007	36
Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man Rajaa A. Mirghani, Örjan Ericsson, Gunnel Tybring, European Journal of Clinical Pharmacology Medicinal ChemistryBiochemistryQuinine 3-HydroxylationMedicineNatural Sciences	2003	35

Page 1